According to Live Science, researchers have identified a key mechanism behind inflammatory bowel disease. In some IBD patients, autoantibodies—essentially antibodies the body produces against itself—may be disrupting the immune system's natural anti-inflammatory controls. Think of it as sabotage from within: these rogue antibodies disable the switches that tell inflammation to stop. This discovery could help explain why IBD develops in certain individuals and potentially point toward new treatments. The research underscores a troubling reality of autoimmune diseases: sometimes the body's defense system turns against its own allies.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton